Intravesical chemotherapy combination provides effective treatment alternative for non-muscle invasive bladder cancer
Research team reports on new treatment option for brain tumors that relapse or fail to respond to standard of care
27 July 2022Bacteria that causes rare tropical disease found in US soil
27 July 2022Intravesical chemotherapy combination provides effective treatment alternative for non-muscle invasive bladder cancer
A combination of two intravesical chemotherapy drugs—gemcitabine and docetaxel—yields high response rates with good tolerability in patients with high-risk non-muscle-invasive bladder cancer (NMIBC), reports a study in The Journal of Urology.
